Combining GLP-1 receptor agonists and SGLT-2 inhibitors for cardiovascular disease prevention in type 2 diabetes: A systematic review with multiple network meta-regressions

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

1290

Figures (1-2)

Tables (1-3)

157

Sum=1539

Publishing Process of This Article

Item

Count

Browse

Download

Sum=42

Oct 15, 2024 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Diabetes. Oct 15, 2024; 15(10): 2135-2146
Published online Oct 15, 2024. doi: 10.4239/wjd.v15.i10.2135

Full Size Figure Download Figure

Figure 1 PRISMA flow diagram with search algorithm. CVOT: Cardiovascular outcome trials.

Citation: Zhu JJ, Wilding JPH, Gu XS. Combining GLP-1 receptor agonists and SGLT-2 inhibitors for cardiovascular disease prevention in type 2 diabetes: A systematic review with multiple network meta-regressions. World J Diabetes 2024; 15(10): 2135-2146
URL: https://www.wjgnet.com/1948-9358/full/v15/i10/2135.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i10.2135